Citi Pharma

Pakistan-based pharmaceutical company Citi Pharma Ltd is entering into a joint venture (JV) agreement with China’s Hangzhou Newsea Technology Co., Ltd, in a strategic move designed to expand Citi’s pharmaceutical Active Pharmaceutical Ingredient (API) manufacturing capabilities. The new entity, to be named Etaci Ltd, will see Citi holding a majority…